![Fabrice Chouraqui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fabrice Chouraqui
Algemeen Directeur bij
PHARMING GROUP N.V.
Vermogen: 221 838 $ op 30-06-2026
Profiel
Fabrice Chouraqui is currently Chief Executive Officer & Executive Director at Pharming Group NV since 2025 and serves as an Independent Member on the Governors Board at Orano Med SAS. Former roles include Chief Executive Officer & Director at Cellarity Inc. and President at Novartis Pharmaceuticals Corp.
from 2016 to 2019.
Education includes an MBA from INSEAD and graduate and doctorate degrees from Universite Paris Cite.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PHARMING GROUP NV 0,02% | 31-03-2026 | 161.425 ( 0,02% ) | 221 838 $ | 30-06-2026 |
Laatste nieuws over Fabrice Chouraqui
Actieve functies van Fabrice Chouraqui
| Bedrijven | Functie | Begin |
|---|---|---|
| PHARMING GROUP N.V. | Algemeen Directeur | 04-03-2025 |
Orano Med SAS
 Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Directeur/Bestuurslid | - |
Eerdere bekende functies van Fabrice Chouraqui
| Bedrijven | Functie | Einde |
|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | President | 01-01-2019 |
Cellarity Inc.
 Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Algemeen Directeur | 12-05-2025 |
Opleiding van Fabrice Chouraqui
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
53
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Health Technology |
Universite Paris Cite
 Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
